Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Hereditary paraganglioma syndrome has recently been shown to be caused by germline heterozygous mutations in three (SDHB, SDHC, and SDHD) of the four genes that encode mitochondrial succinate dehydrogenase. Extraparaganglial component neoplasias have never been previously documented. In a population-based registry of symptomatic presentations of phaeochromocytoma/paraganglioma comprising 352 registrants, among whom 16 unrelated registrants were SDHB mutation positive, one family with germline SDHB mutation c.847-50delTCTC had two members with renal cell carcinoma (RCC), of solid histology, at ages 24 and 26 years. Both also had paraganglioma. A registry of early-onset RCCs revealed a family comprising a son with clear-cell RCC and his mother with a cardiac tumor, both with the germline SDHB R27X mutation. The cardiac tumor proved to be a paraganglioma. All RCCs showed loss of the remaining wild-type allele. Our observations suggest that germline SDHB mutations can predispose to early-onset kidney cancers in addition to paragangliomas and carry implications for medical surveillance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, clinical similarities besides pheochromocytoma have been noted in families with germline mutations of VHL and SDHB [26].”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [26]
Citations
Cites
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 3×
“00 cinate dehydrogenase (SDH), were described in families with head and neck PGLs (Baysal et al. 2000).”
BackgroundInfluentialThe Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635 · cited 6×
“It is interesting that germline FH mutations are associated with HLRCC (Tomlinson et al. 2002).”
BackgroundInfluentialOhh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Self-citationNickerson, M. L., Warren, M. B., Toro, J. R., Matrosova, V., Glenn, G., Turner, M. L., Duray, P., Merino, M., Choyke, P., Pavlovich, C. P., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00104-6 · Cited by 940 · cited 2×
“Germline mutations in HRPT2 have been recently associated with hyperparathyroidism jaw tumor syndrome (MIM 145001), and germline mutations in BHD, encoding folliculin, have been associated with Birt-Hogg-Dubé syndrome (MIM 135150); both of these diseases have RCC as component tumors (Khoo et al. 2002; Nickerson et al.…”
BackgroundChen, F., Kishida, T., Yao, M., Hustad, T., Glavac, D., Dean, M., Gnarra, J. R., Orcutt, M. L., Duh, F. M., Glenn, G., et al. (1995) · Human Mutation · doi:10.1002/humu.1380050109 · Cited by 556
Activating mutations for the Met tyrosine kinase receptor in human cancer
Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C. P., Weirich, G., Kishida, T., Zbar, B., & Vande Woude, G. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11445 · Cited by 442 · cited 4×
“Accumulation of reactive oxygen species could result from dysfunction in mitochondrial energy metabolism; results supporting this theory have been reported (Jeffers et al. 1997; Eng et al. 2003).”
BackgroundResultInfluentialA role for mitochondrial enzymes in inherited neoplasia and beyond
Eng, C., Kiuru, M., Fernandez, M. J., & Aaltonen, L. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1013 · Cited by 392 · cited 10×
“It is interesting that germline mutations in genes encoding two other subunits of SDH (mitochondrial complex II), SDHB (MIM 185470 and MIM 605373) and SDHC (MIM 602413), were found to be associated with heritable pheochromocytoma and/or PGL (Maher and Eng 2002; Eng et al. 2003).”
BackgroundResultInfluentialSelf-citation
Cited by
Items 201–300 of 387
SDH-deficient renal cell carcinoma – clinical, pathologic and genetic correlates: a case report
Kumar, R., Bonert, M., Naqvi, A. H., Zbuk, K. M., & Kapoor, A. (2018) · BMC Urology · doi:10.1186/s12894-018-0422-8 · Cited by 25
Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma
Karivedu, V., Jain, A., Eluvathingal, T. J., & Sidana, A. (2019) · Current Urology Reports · doi:10.1007/s11934-019-0932-2 · Cited by 25
Research progress on the pathogenesis of the SDHB mutation and related diseases
Liu, C., Zhou, D., Yang, K., Xu, N., Peng, J., & Zhu, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115500 · Cited by 26
The role of mutation of metabolism-related genes in genomic hypermethylation
Waterfall, J. J., Killian, J. K., & Meltzer, P. S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.003 · Cited by 24
Genetically Modeled Mice with Mutations in Mitochondrial Metabolic Enzymes for the Study of Cancer
Piruat, J. I., & Millán‐Uclés, Á. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00200 · Cited by 23
SDHB variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma
Bayley, J., Bausch, B., Jansen, J. C., Hensen, E. F., van der Tuin, K., Corssmit, E. P. M., Devilee, P., & Neumann, H. P. H. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107656 · Cited by 24
Self-citationSkonieczna, K., Malyarchuk, B. А., & Grzybowski, T. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.11.004 · Cited by 26
Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome
Raymond, V. M., Herron, C. M., Giordano, T. J., & Gruber, S. B. (2011) · Familial Cancer · doi:10.1007/s10689-011-9485-3 · Cited by 21
Mitochondrial metabolic remodeling in response to genetic and environmental perturbations
Hollinshead, K. E. R., & Tennant, D. A. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1334 · Cited by 24
PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation?
Yehia, L., & Eng, C. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa127 · Cited by 21
“We noticed an increased incidence of thyroid and renal cancers, which are PHTS component cancers (44), in our PCC/PGL registry (49,50), and explored SDHx as”
BackgroundSelf-citationPediatric paraganglioma: An early manifestation of an adult disease secondary to germline mutations
Mora, J., Cascón, A., Robledo, M., & Català, A. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20680 · Cited by 21
The clinical genetics of phaeochromocytoma and paraganglioma
Gunawardane, P. T. K., & Grossman, A. B. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000299 · Cited by 23
“Apart from catecholamine secreting tumours, genetic defects in the SDH complex less frequently gives rise to renal cell carcinomas and gastro- intestinal stromal tumours (GISTs), and more recently to pituitary adenomas (28-31).”
BackgroundHereditary succinate dehydrogenase-deficient renal cell carcinoma
Rogala, J., & Zhou, M. (2023) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2023.11.001 · Cited by 21
Gupta, S., Zhang, J., Milosevic, D., Mills, J. R., Grebe, S. K. G., Smith, S. C., & Erickson, L. A. (2017) · Endocrine Pathology · doi:10.1007/s12022-017-9489-0 · Cited by 23
Imaging findings of hereditary renal tumors, a review of what the radiologist should know
Czarniecki, M., Gautam, R., Choyke, P. L., & Türkbey, B. (2018) · European Journal of Radiology · doi:10.1016/j.ejrad.2018.01.026 · Cited by 20
Genetic Basis of Bilateral Renal Cancer: Implications for Evaluation and Management
Linehan, W. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0045 · Cited by 20
Rao, Q., Xia, Q., Liang Cheng, C., & Zhou, X. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2016.01.03 · Cited by 19
Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer
Kirches, E. (2009) · Current Genomics · doi:10.2174/138920209788488517 · Cited by 21
“The genetic analysis of PGL-1 families [28] led to the discovery that the SDHD gene, encoding the small cytochrome b subunit within the mitochondrial succinate dehydrogenase complex (SDH) is responsible for PGL-1.”
BackgroundInfluentialRaygada, M. J., King, K. S., Adams, K. T., Stratakis, C. A., & Pacák, K. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0369 · Cited by 23
The growing family of hereditary renal cell carcinoma
Richard, S., Lidereau, R., & Giraud, S. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh535 · Cited by 18
“Three cases of clear cell RCC occurring at a young age have been reported recently in patients with germline mutations in the SDHB gene (located in 1p36) [20].”
BackgroundEpidemiology of Renal Cell Carcinoma
Narayanan, S., Patel, P. H., Fan, A. C., & Srinivas, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_1 · Cited by 18
Precision medicine for metastatic renal cell carcinoma
Sonpavde, G., & Choueiri, T. K. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.07.010 · Cited by 17
Lee, C., Chen, Y., Wang, P., Wallace, D. C., & Burke, P. J. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03244 · Cited by 18
Metabolomics in paraganglioma: applications and perspectives from genetics to therapy
Richter, S., Garrett, T. J., Bechmann, N., Clifton-Bligh, R. J., & Ghayee, H. K. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0376 · Cited by 16
A study exploring critical pathways in clear cell renal cell carcinoma
Zeng, Z., Que, T., Zhang, J., & Hu, Y. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1392 · Cited by 19
Succinat-Dehydrogenase(SDH)-defizientes Nierenzellkarzinom
Agaimy, A. (2016) · Der Pathologe · doi:10.1007/s00292-016-0158-8 · Cited by 17
“Sustentakularzellenbei Paragangliomen) etc. stark granular angefärbt sein Bei Defizienz müssen die Tumorzellen komplett negativ „sauber“ sein Auf eine On-slide-Kontrolle sollte man bei SDH-Färbung besser verzichten Interpretation der SDHBFärbung Kräftige Anfärbung wie oben beschrieben, sowohl im Tumor als auch im Norm…”
MethodInfluentialUpdate on the Molecular Diagnosis of Endocrine Tumors: Toward –omics-Based Personalized Healthcare?
Weber, F., & Eng, C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0212 · Cited by 16
“Interestingly, very-early-onset ( 30 yr old) renal cell carcinoma, of an unusual solid histology, may be seen in those with SDHB germline mutations (57, 59).”
BackgroundSelf-citationBausch, B., Boedeker, C. C., Berlis, A., Brink, I., Cybulla, M., Walz, M. K., Januszewicz, A., Letizia, C., Opocher, G., Eng, C., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.013 · Cited by 18
Self-citationCatherino, W. H., Mayers, C. M., Mantzouris, T., Armstrong, A. Y., Linehan, W. M., & Segars, J. H. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.198 · Cited by 16
Ueno, D., Vasquez, J. C., Sule, A. D., Liang, J., Doorn, J. V., Sundaram, R. K., Friedman, S., Caliliw, R., Ohtake, S., Bao, X., et al. (2022) · Oncotarget · doi:10.18632/oncotarget.28273 · Cited by 16
“The majority of SDH-deficient renal cancers involve mutations in SDHB, and these tumors can similarly behave aggressively with early age of onset [7, 8].”
BackgroundHereditary renal cell carcinoma: genetics, clinical features, and surgical considerations
Byler, T. K., & Bratslavsky, G. (2014) · World Journal of Urology · doi:10.1007/s00345-014-1287-4 · Cited by 17
“While a hereditary component to succinate dehydrogenase (SDH) has been reported, it was only recently that its genetics and correlation to early onset rcc was established [40].”
BackgroundMorphological clues to the appropriate recognition of hereditary renal neoplasms
Moch, H., Ohashi, R., Gandhi, J. S., & Amin, M. B. (2018) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2018.01.005 · Cited by 17
Identification of alternatively spliced GRIM-19 mRNA in kidney cancer tissues
He, X., & Cao, X. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.57 · Cited by 16
Eng, C. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn263 · Cited by 16
“847delTCTC Solid 26 PGL (34) 36 Deceased Vanharanta (13) Neumann (8) 6 Trp47X Papillary, II 26 PGL (10) 27 Srirangalingam (20)”
BackgroundSelf-citationTuthill, M. H., Barod, R., Pyle, L., Cook, H. T., Chew, S. L., Gore, M. E., Maxwell, P. H., & Eisen, T. G. (2009) · BMJ Case Reports · doi:10.1136/bcr.08.2008.0732 · Cited by 14
Neuroendocrine Tumors and Tumor Syndromes in Childhood
Gaal, J., & de Krijger, R. R. (2009) · Pediatric and Developmental Pathology · doi:10.2350/09-04-0635-cp.1 · Cited by 15
Molecular and therapeutic landscape of non-clear cell renal carcinoma
Nepali, P. R., Eraky, A., Okhawere, K. E., Dogra, N., Mehrazin, R., Badani, K. K., & Kyprianou, N. (2025) · Nature Reviews Urology · doi:10.1038/s41585-025-01056-0 · Cited by 16
“Results from the analysis of data from a registry of early-onset RCCs showed that a mother and son, both with a germline SDHB R27X mutation, had a cardiac tumour (paraganglioma) and clear-cell RCC, respectively 112 .”
Yang, J., Miao, D., Li, X., Zhao, C., Tan, D., Wu, S., Lu, F., Shi, J., Lv, Q., Ruan, H., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1664292 · Cited by 15
Focus on Mitochondrial Respiratory Chain: Potential Therapeutic Target for Chronic Renal Failure
Wang, Y., Yang, J., Zhang, Y., & Zhou, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020949 · Cited by 19
“Nonetheless, considering the fibrosis-promoting effect of glycolysis and the incomplete energy compensation, exploring kidney damage resulting from mutations linked to complex II is necessary [105].”
BackgroundDopamine-secreting Carotid Body Paragangliomas-Biochemical Control with Radiotherapy
Soh, A. W. E., & Kek, P. C. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.6324 · Cited by 13
“SDHB mutations have been associated with malignant disease (27), extra-adrenal paragangliomas (28), and other extra-paraganglial tumors, for example renal cell carcinoma (29).”
BackgroundNicolas, É., Demidova, E. V., Iqbal, W., Serebriiskii, I. G., Vlasenkova, R., Ghatalia, P., Zhou, Y., Rainey, K., Forman, A. F., Dunbrack, R. L., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.556 · Cited by 15
Les cancers du rein héréditaires vus par le pathologiste en 2020
Verkarre, V., Morini, A., Denize, T., Ferlicot, S., & Richard, S. (2020) · Annales de Pathologie · doi:10.1016/j.annpat.2020.02.022 · Cited by 15
Rubinstein, W. S. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.06.008 · Cited by 15
Cascón, A., Cebrián, A., Pollán, M., Ruiz‐Llorente, S., Montero‐Conde, C., Letón, R., Gutiérrez, R. J., Lesueur, F., Milne, R. L., Albarrán, O. G., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2059 · Cited by 12
Mutation profiling in eight cases of vagal paragangliomas
Kudryavtseva, A. V., Kalinin, D. V., Pavlov, V., Savvateeva, M. V., Fedorova, M., Pudova, E. A., Kobelyatskaya, A. A., Golovyuk, A. L., Guvatova, Z. G., Razmakhaev, G. S., et al. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-00763-4 · Cited by 12
Nan, H., Guo, P., Fan, J., Zeng, W., Hu, C., Zheng, C., Pan, B., Cao, Y. J., Ge, Y., Xue, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1093974 · Cited by 11
“SDH mutations have been found in familial paragangliomas and pheochromocytomas (19–24), renal carcinomas (25), and gastrointestinal stromal tumors (26).”
BackgroundHuang, H., Tang, Y., He, W., Huang, Q., Zhong, J., & Yang, Z. (2013) · International Urology and Nephrology · doi:10.1007/s11255-013-0511-2 · Cited by 11
Urological cancer related to familial syndromes
da Costa, W. H., Netto, G. J., & da Cunha, I. W. (2017) · International braz j urol · doi:10.1590/s1677-5538.ibju.2016.0125 · Cited by 12
Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism
Tevosian, S. G., & Ghayee, H. K. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01991 · Cited by 12
“renal carcinomas (45), T-cell leukemia (46), and gastrointestinal stromal tumors (47, 48).”
BackgroundThe Metabolic Basis of Kidney Cancer
Srinivasan, R., George, A. K., & Linehan, W. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_6 · Cited by 11
TBX15 and SDHB expression changes in colorectal cancer serve as potential prognostic biomarkers
Golozar, M., Motlagh, A. V., Mahdevar, M., Peymani, M., InanlooRahatloo, K., & Ghaedi, K. (2024) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2024.104890 · Cited by 10
Defining the origin, evolution, and immune composition of SDH-deficient renal cell carcinoma
Neves, J. B., Roberts, K., Sivakumaran, S., Sheikh, S. E., Tran‐Dang, M., Horsfield, C. J., Mumtaz, F., Campbell, P. J., Stauss, H. J., Tran, M. G. B., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105389 · Cited by 13
Jandová, J., Eshaghian, A., Shi, M., Li, M., King, L. E., Janda, J., & Sligh, J. E. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.320 · Cited by 11
“…M anuscript and mutations in subunits of the succinate dehydrogenase gene (SDHB, SHDC, SDHD) have been associated with paragangliomas, pheochromocytomas and renal cell carcinomas (Baysal et al., 2000; Niemann and Muller 2000; Astuti et al., 2001; Lehtonen et al., 2004; Vanharanta et al., 2004).”
BackgroundSignalling pathways in succinate dehydrogenase B ‐associated renal carcinoma
Fleming, S., Mayer, N. J., Vlatkovic, L., McLean, J., McConachie, M., & Baty, D. U. (2013) · Histopathology · doi:10.1111/his.12250 · Cited by 10
“The association of renal carcinoma with germline mutations of the gene encoding the mitochondrial electron transport/Krebs cycle component succinate dehydrogenase B subunit has emerged in recent years.(4) Observations by ourselves and others have shown that these tumours have a distinct morphology characterized by abu…”
BackgroundShuch, B. M., Mmonu, N. A., Ricketts, C. J., Vocke, C. D., Gautam, R., Merino, M. J., Linehan, W. M., & Srinivasan, R. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.0214 · Cited by 10
“Kidney cancer was first recognized as a manifestation of the SDHB syndrome when a renal tumor from a patient with a known SHDB germline mutation was found to have loss of heterozygosity (LOH) of the wild-type SDHB gene allele.(7) Ricketts et al(8) later dem-”
Epidemiology of Renal Cell Carcinoma
Patel, P. H., & Srinivas, S. (2011) · Springer eBooks · doi:10.1007/978-3-642-21858-3_1 · Cited by 14
Das Phäochromozytom – noch immer eine Herausforderung
Reisch, N., Walz, M. K., Erlic, Z., & Neumann, H. P. H. (2008) · Der Internist · doi:10.1007/s00108-008-2196-7 · Cited by 12
Self-citationMitochondria-Associated Pathways in Cancer and Precancerous Conditions: Mechanistic Insights
Li, L., Pan, D., Ai, R., & Zhou, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178537 · Cited by 11
“Mutations and deficiencies in SDHB (encoding one of the subunits of SDH in CII) have been linked to early-onset renal cell carcinoma, with abnormal protein disrupting electron flow and increasing ROS production [21].”
Phenotype of SDHB mutation carriers in the Netherlands
van Hulsteijn, L. T., Niemeijer, N. D., Hes, F. J., Bayley, J., Tops, C. M. J., Jansen, J. C., & Corssmit, E. P. M. (2014) · Familial Cancer · doi:10.1007/s10689-014-9738-z · Cited by 10
GENETIC SYNDROMES ASSOCIATED WITH RENAL CELL CARCINOMA - A REVIEW
Azeem, K., Kollárová, H., Horáková, D., Magnusková, S., & Janout, V. (2011) · Biomedical Papers · doi:10.5507/bp.2011.029 · Cited by 9
Turano, M., Vicidomini, R., Cammarota, F., D’Agostino, V., Duraturo, F., Izzo, P., & Rosa, M. D. (2023) · Biomedicines · doi:10.3390/biomedicines11051428 · Cited by 9
Liu, J., Wang, Y., Wang, X., Li, Y., Jiang, Y., Li, Y., Zhang, W. Y., & Yu, W. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155459 · Cited by 8
Means, Motive, and Opportunity: SDH Mutations Are Suspects in Pituitary Tumors
Beckers, A. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2125 · Cited by 8
Hansel, D. E., & Rini, B. I. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.6.895 · Cited by 12
Familial endocrine tumours: phaeochromocytomas and extra-adrenal paragangliomas
Komminoth, P., Perren, A. A., van Nederveen, F. H., & de Krijger, R. R. (2009) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2009.01.003 · Cited by 11
MacLennan, G. T., & Liang Cheng, C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-01970-5.50004-x · Cited by 15
Hereditary Kidney Cancer Syndromes and Surgical Management of the Small Renal Mass
Nguyen, K. A., Syed, J. S., & Shuch, B. M. (2017) · Urologic Clinics of North America · doi:10.1016/j.ucl.2016.12.002 · Cited by 7
Common alleles of predisposition in endocrine neoplasia
Eng, C. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.02.004 · Cited by 7
Self-citationImaging evaluation of hereditary renal tumors: a pictorial review
Tanaka, T., Kawashima, A., Marukawa, Y., Kitayama, T., Masaoka, Y., Kojima, K., Iguchi, T., Hiraki, T., & Kanazawa, S. (2021) · Japanese Journal of Radiology · doi:10.1007/s11604-021-01109-5 · Cited by 8
SDH‐deficient renal cell carcinoma: A case report associated with a novel germline mutation
Milionis, V., Goutas, D., Vlachodimitropoulos, D. G., Katsoulas, N., Kyriazis, I. D., LIATSIKOS, E. N., Marinakis, N. M., Traeger‐Synodinos, J., Lazaris, A. C., & Goutas, N. D. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4605 · Cited by 6
Domingues, R., Montalvão, P., Magalhães, M. J., Santos, R. M., Duarte, L., & Bugalho, M. J. (2012) · PubMed · doi:10.3275/8237 · Cited by 9
Milione, M., Pusceddu, S., Gasparini, P., Melotti, F., Maisonneuve, P., Mazzaferro, V., de Braud, F., & Pelosi, G. (2012) · Cancers · doi:10.3390/cancers4030808 · Cited by 7
“is a highly conserved heterotetrameric protein, with SDHA and SDHB functioning as catalytic subunits, which protrudes into the mitochondrial matrix and is anchored to the inner membrane by means of SDHC and SDHD subunits, the latter also providing the binding site for ubiquinone [15–40].”
BackgroundWallace, D. C., Lott, M. T., & Procaccio, V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00013-6 · Cited by 9
Molecularly defined renal cell carcinomas: practical approaches for surgical pathologists
Akgül, M., George, R. S., Siegmund, S., Oktay, M., Sangoi, A. R., Williamson, S. R., & Liang Cheng, C. (2025) · Histopathology · doi:10.1111/his.70039 · Cited by 6
Bausch, B., Malinoc, A., Maruschke, L., Offergeld, C., Gläsker, S., Rischke, H. C., Brauckhoff, M., Boedeker, C. C., & Neumann, H. P. H. (2012) · Der Chirurg · doi:10.1007/s00104-011-2191-8 · Cited by 6
Self-citationSuccinate dehydrogenase–deficient renal cell carcinoma: A case report and review of the literature
Sun, A., Liu, Z., Wang, T., & Xing, J. (2021) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2021.01.025 · Cited by 6
Genetic Testing by Cancer Site
Chan–Smutko, G. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31826246ac · Cited by 6
“Earlier reports of families with mutations in SDHB also noted renal tumors in a minority of these families with a paraganglioma/pheochromocytoma phenotype.(27) Different renal tumor histologic findings have been reported including clear cell, chromophobe, carcinoma not classifiable, papillary type 2, or oncocytoma.”
BackgroundCanu, L., Puglisi, S., Berchialla, P., Filpo, G. D., Brignardello, F., Schiavi, F., Ferrara, A. M., Zovato, S., Luconi, M., Pia, A. R., et al. (2021) · Cancers · doi:10.3390/cancers13225831 · Cited by 6
“In fact, SDHx mutations have been associated with renal cell carcinomas (RCCs) [5], gastrointestinal stromal tumors (GISTs) [6,7] and pituitary adenomas (PAs) [6].”
BackgroundOxidative Stress and Redox-Signaling in Renal Cell Cancer
Block, K. L. (2012) · InTech eBooks · doi:10.5772/26747 · Cited by 7
“The tricarboxylic acid (TCA)/Krebs cycle is part of a metabolic pathway coupled to mitochondrial oxidative phosphorylation that converts nutrients to energy in aerobic cells. www.intechopen.com Oxidative Stress and Redox-Signaling in Renal Cell Cancer 145 The fumarate hydratase (FH) and succinate dehydrogenase (SDH) g…”
BackgroundInfluentialGenetic insights into the hypoxia-inducible factor (HIF) pathway
Kiriakidis, S., Esteban, M. A., & Maxwell, P. H. (2007) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.12.009 · Cited by 6
Du, X., Wan, S., Chen, Y., Qü, P., Huang, X., Yu, X., Yang, H., Zhang, Y., & Xing, J. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3876-2 · Cited by 7
Detection of Mitochondrial Mutations in Cancer by Next Generation Sequencing
Ye, F., & David, C. (2014) · Journal of Next Generation Sequencing & Applications · doi:10.4172/2469-9853.1000102 · Cited by 5
“Since then, various studies have shown that mutations in mtDNA can contribute to cancer etiology [9,10] and mtDNA mutations are associated with various types of cancer, including breast cancer [11], prostate cancer [12,13], head and neck cancer [14], colon cancer [15], and bladder cancer [16,17].”
BackgroundMolecular genetics of pheochromocytoma/paraganglioma
Wachtel, H., & Nathanson, K. L. (2024) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2024.100527 · Cited by 10
R27X nonsense mutation of the SDHB gene in a patient with sporadic malignant paraganglioma
Naito, M., Usui, T., Tamanaha, T., Kawashima, S., Iogawa, H., Hagiwara, H., Kimura, T., Tagami, T., Kurosawa, M., Shimatsu, A., et al. (2009) · Endocrine · doi:10.1007/s12020-009-9204-0 · Cited by 5
“The R27X mutation was previously reported in two families; one case from Finland that had cardiac paraganglioma and early-onset renal cell carcinoma [12, 15], and another case from Germany that carried the nonsense mutation [20].”
BackgroundPrasad, P. K., Kant, J. A., Wills, M. L., O’Leary, M. F., Lovvorn, H. N., & Yang, E. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.04.009 · Cited by 6
“Loss of the wild-type SDHB allele in tumor DNA was reported by direct sequencing of a renal cell carcinoma in two individuals [11].”
BackgroundSato, H., Kanai, G., Hirabayshi, K., Kajiwara, H., Itoh, J., & OSAMURA, R. Y. (2010) · Endocrine · doi:10.1007/s12020-010-9365-x · Cited by 5
Epidemiology of Renal Cell Carcinoma
Sánchez, A., Allard, C. B., & Wilson, K. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_17 · Cited by 5
Pheochromocytoma and the Multiple Endocrine Neoplasia Syndromes
Chernausek, S. D., & Eng, C. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50018-1 · Cited by 5
Self-citationPheochromocytoma and multiple endocrine neoplasia syndromes
Waguespack, S. G., & Ying, A. K. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00023-8 · Cited by 7
Dai, Z., Wang, X., Zhang, Y., Qiu, Y., & Liu, J. (2024) · Oncology Letters · doi:10.3892/ol.2024.14485 · Cited by 4
“In 2004, Vanharanta et al (4) first reported SDH‑deficient RCC. SDH‑deficient RCC was subsequently included as a new subtype of RCC in the 2016 edition of the World Health Organization classification of renal tumors (5).”
BackgroundChaurasia, A., Turkbey, E. B., Firouzabadi, F. D., Singh, S. M., Samimi, S., Gopal, N., Millo, C., Ball, M. W., Linehan, W. M., & Malayeri, A. A. (2024) · Clinical Imaging · doi:10.1016/j.clinimag.2024.110280 · Cited by 4
Renal cell carcinoma with succinate dehydrogenase A mutation: A case report and literature review
Hu, M., Wang, X., Xiao, X.-X., Rao, Q., Fan, L., & Yue, J. (2024) · Oncology Letters · doi:10.3892/ol.2024.14830 · Cited by 4
“SDH‑deficient RCC is a specific type of RCC that was first proposed in 2004 by Vanharanta et al (4), recognized by the International Society for Urological Pathology (ISUP) Vancouver in 2013 (5), and formally included as a subtype of RCC by the World Health Organization (WHO) in 2016 (6).”
The Genetic Basis of Kidney Cancer and Implications for Targeted Therapies
Schmidt, L. S., Srinivasan, R., & Linehan, W. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_1 · Cited by 4
Filpo, G. D., Cilotti, A., Rolli, L., Pastorino, U., Sonzogni, A., Pradella, S., Cantini, G., Ercolino, T., Nesi, G., Mannelli, M., et al. (2020) · Medicina · doi:10.3390/medicina56110561 · Cited by 4
Ali, K., Zhou, M., Campbell, S. C., Bukowski, R. M., & Rini, B. I. (2012) · doi:10.1002/9781118464557.ch1 · Cited by 4
Gao, Y., Xiong, Z., & Wei, X. (2025) · Metabolites · doi:10.3390/metabo15080513 · Cited by 6
Kim, Y., Kim, J., Hwang, K., Park, K. C., Cheong, J., & Sim, T. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118081 · Cited by 6
Metabolic Changes and Their Characterization
Ain, N.-U., & Gull, H. (2020) · Springer eBooks · doi:10.1007/978-981-15-1067-0_2 · Cited by 3
Keratin 20 positive SDH-deficient renal cell carcinoma: a case report and literature review
Dong, S., Wang, Z.-Y., Tian, X.-C., Wang, C.-M., Xu, Q., Xu, C., Yang, W., Gu, X., & Xiao, Q. (2024) · Diagnostic Pathology · doi:10.1186/s13000-024-01561-7 · Cited by 3
“Whereas SDH -deficient renal cell carcinoma ( SDH -deficient RCC) was first discovered in 2004 [1].”
BackgroundHereditary Syndromes Involving Pheochromocytoma and Paraganglioma
Geurts, J. L., Rich, T. A., Evans, D. B., & Wang, T. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00016-6 · Cited by 3
Metadata
- Authors
- Vanharanta, S., Buchta, M., McWhinney, S. R., Virta, S. K., Peçzkowska, M., Morrison, C. D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., Mecklin, J.-P., Pukkala, E., Herva, R., Kiuru, M., Nupponen, N. N., Aaltonen, L. A., Neumann, H. P. H., & Eng, C.
- Affiliations
- University of Helsinki (FI)
- University of Freiburg (DE)
- The Ohio State University (US)
- Institute of Cardiology (PL)
- Helsinki University Hospital (FI)
- Central Finland Health Care District (FI)
- Finnish Cancer Registry (FI)
- Oulu University Hospital (FI)
- University of Cambridge (GB)
- Corresponding author
- Eng, Charis
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 74
- Issue
- 1
- Pages
- 153-159
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1181902
- OpenAlex
- W1977015709
- Cited by
- 389
- References
- 24
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 14 · 2023: 11 · 2022: 14 · 2021: 20 · 2020: 12 · 2019: 22 · 2018: 16 · 2017: 20 · 2016: 20 · 2015: 21 · 2014: 32 · 2013: 26 · 2012: 29
- FWCI
- 13.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3487 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (NE571/4-1)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD039058, R01 HD39058, R01HD39058-02S1)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- SDHB mutation, hereditary paraganglioma, succinate dehydrogenase, clear cell renal cell carcinoma, cardiac paraganglioma, germline mutations, loss of heterozygosity, cancer susceptibility, medical surveillance
- MeSH terms
- Adolescent, Adult, Base Sequence, Carcinoma, Renal Cell, Female, Humans, Iron-Sulfur Proteins, Kidney Neoplasms, Male, Paraganglioma, Pedigree, Succinate Dehydrogenase, Sequence Deletion, Age of Onset, Germ-Line Mutation, Genetic Predisposition to Disease, Mutation, Missense, Protein Subunits, Siblings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.